Racial differences responses thrombolytic therapy recombinant tissue-type plasminogen activator fibrin ogen olysis blacks Thrombolysis Angioplasty Myocardial Infarction Study Group differences responses thrombolytic therapy certain populations data Thrombolysis Angioplasty Myocardial Infarction study black white patients Baseline risk factors extent coronary artery disease similar white black patients time onset chest pain tissue-type plasminogen activator rt-PA therapy rt-PA dosing regimens groups patency rate infarct-related artery minutes blacks whites Blacks nadir fibrinogen levels versus g/l delta fibrinogen baseline-nadir versus g/l peak levels fibrin ogen degradation products versus micrograms/ml rt-PA antigen levels blacks whites versus micrograms/ml peak versus micrograms/ml end maintenance infusion Major clinical outcomes survival time hospital discharge black versus white different angioplasty procedures blacks transfusions equal units erythrocytes 